Researchers at the University of Bonn and the University Hospital Bonn have successfully reprogrammed blood cell precursors from an 80-year-old donor into neural stem cells, reversing the molecular age of the cells by more than 60 years. The findings, published in the peer-reviewed journal Aging Cell, demonstrate that cellular aging processes can be partially reversed in a laboratory setting without first stripping cells back to a blank pluripotent state.
The study, conducted in collaboration with the Technischen Hochschule Aachen, details a direct conversion method that tracked epigenetic changes over a period exceeding 100 days. While the technique does not cure human aging or reverse neurodegenerative conditions in patients, it provides scientists with a novel experimental model to observe how cellular aging unfolds and to test potential therapeutic compounds.
Direct Reprogramming of Blood Precursors into Neural Stem Cells
Human bodies contain hundreds of specialized cell types, such as skin, liver, and blood cells, which normally cannot change their assigned biological functions. To bypass this restriction, the Bonn research team used blood samples obtained from donors ranging from newborns to 101-year-olds. The investigators used proteins to introduce specific instructions into the cells.
These introduced protein factors, identified as SOX2 and cMYC, direct which genes a cell reads and thus determine its functional identity. Rather than taking the conventional two-step approach of returning a mature cell to a pluripotency baseline before differentiating it anew, the team directed the blood precursors straight into neural stem cells. Cultured over 50 days, the cells underwent a gradual transformation while shedding molecular indicators of age.
Epigenetic Clock Measurements Reveal Teenager Profiles in Elderly Tissue
To quantify the biological age of the manipulated tissue, the researchers used an epigenetic clock that tracks chemical modifications on DNA without altering the underlying genetic sequence. These chemical shifts influence gene activity and change predictably over time.
Before the procedure, samples from an 80-year-old donor carried age-associated markers typical of advanced years. Following the 50-day reprogramming window, the molecular signature of those same cells aligned with the profile of an individual under the age of 20. Summary data from the study indicate stem cells derived from older donors retain roughly 13 percent of their starting age in early passages and drop to about 5 percent after many passages, representing an even steeper reduction when applied to an 80-year-old.
Experimental Models for Alzheimer Disease and Neurodegeneration
Oliver Brüstle, director of the Institute for Reconstructive Neurobiology at the University Hospital Bonn, emphasized the utility of the slow, gradual rejuvenation process observed in the laboratory. Because the epigenetic clock wound backward incrementally over several weeks rather than instantaneously, the setup provides an ideal testing ground.
While the technique successfully strips away certain age-related chemical signatures, accumulated damage and changes that have collected in the genetic material over decades remain. Consequently, the procedure serves strictly as an investigative tool rather than a clinical anti-aging treatment. By maintaining old cells in culture dishes, researchers can now evaluate which pharmacological substances accelerate or slow down the rejuvenation timeline, offering a direct view into the cellular mechanisms underlying Alzheimer disease and other age-related neurological disorders.
Frequently Asked Questions About Cellular Rejuvenation
How long did the laboratory reprogramming process take to complete?
The transformation of blood cell precursors into neural stem cells took place over a culturing period of 50 days, though researchers tracked the gradual epigenetic changes for more than 100 days.
Can this laboratory method be used to treat patients with Alzheimer disease today?
No, the procedure has been performed exclusively on cells inside laboratory petri dishes. Animal tests and safety evaluations must precede any future clinical applications.
Which specific protein factors were used to convert the blood cells?
The research team utilized two specific protein factors, SOX2 and cMYC, to reprogram the blood-cell precursors directly into neural stem cells.
Related reading